ALINASTINE

Possibly Marketed Outside US

Details

Stereochemistry	ACHIRAL
Molecular Formula	C28H39N3O
Molecular Weight	433.6288
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCOCCN1C(=NC2=CC=CC=C12)C3CCN(CCC4=CC=C(C=C4)C(C)(C)C)CC3

InChI

InChIKey=NPWTVYBPSXCRPM-UHFFFAOYSA-N

InChI=1S/C28H39N3O/c1-5-32-21-20-31-26-9-7-6-8-25(26)29-27(31)23-15-18-30(19-16-23)17-14-22-10-12-24(13-11-22)28(2,3)4/h6-13,23H,5,14-21H2,1-4H3

HIDE SMILES / InChI

Molecular Formula	C28H39N3O
Molecular Weight	433.6288
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://adisinsight.springer.com/drugs/800005210

Alinastine, a histamine H1 receptor antagonist, that was studied for allergic conjunctivitis, for asthma and for skin disorders, but these experiments were discontinued.

Approval Year

PubMed

Title	Date	PubMed

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:16:08 GMT 2023` Edited by `admin` on `Fri Dec 15 16:16:08 GMT 2023`
Record UNII	FDP9A2F6YL
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ALINASTINE

Official Name

English

2-(1-(P-TERT-BUTYLPHENETHYL)-4-PIPERIDYL)-1-(2-ETHOXYETHYL)BENZIMIDAZOLE

Common Name

English

alinastine [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C29578